PATENT CLAIM ANALYSIS

Application Number: 15996544
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-09
Patent Classification: ["514", "218000"]

Abstract:
Provided are novel compounds which are capable of inhibiting an activity of RNA polymerase I, and uses thereof in treating diseases or disorders modulated by RNA polymerase I, preferably autoimmune diseases such as multiple sclerosis and proliferative diseases.

Claim (Index 9):
The method of  claim 1 , wherein said treating comprises suppressing an activity of a typical RRMS course in the subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.28125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14742907', '14935155', '15485106', '15661770', '14708230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7210874020041728
- 35 USC 102 Novelty (BERT): 0.5454743226938034
- Combined Prediction Score: 0.7035260940731358
- Mean Citation Score: 213.92281000000003
- Max Citation Score: 380.62625
- Similarity Product: 142.86740443103017

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test